Assenagon Asset Management S.A. Raises Stock Holdings in DaVita Inc. (NYSE:DVA)

Assenagon Asset Management S.A. grew its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 201.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 74,617 shares of the company's stock after purchasing an additional 49,885 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.09% of DaVita worth $11,159,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Franklin Resources Inc. raised its stake in DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company's stock worth $8,885,000 after acquiring an additional 31,502 shares during the period. FMR LLC boosted its holdings in shares of DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company's stock valued at $29,082,000 after purchasing an additional 154,061 shares during the last quarter. Atom Investors LP purchased a new position in DaVita during the 3rd quarter valued at approximately $4,094,000. Neo Ivy Capital Management bought a new stake in DaVita in the third quarter worth $726,000. Finally, Quest Partners LLC bought a new stake in shares of DaVita in the 3rd quarter worth about $669,000. Hedge funds and other institutional investors own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DVA. Barclays raised their price target on DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. Truist Financial raised their target price on shares of DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $161.80.

DaVita Trading Up 0.9 %

Shares of DVA traded up $1.43 during trading hours on Friday, reaching $166.28. 429,777 shares of the company traded hands, compared to its average volume of 606,593. The stock's fifty day moving average price is $157.11 and its 200 day moving average price is $152.81. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The firm has a market cap of $13.63 billion, a price-to-earnings ratio of 17.94, a PEG ratio of 0.75 and a beta of 0.92. DaVita Inc. has a 12-month low of $103.40 and a 12-month high of $169.51.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion during the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter in the prior year, the company posted $2.85 earnings per share. DaVita's quarterly revenue was up 4.6% compared to the same quarter last year. Sell-side analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.